- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 14, 2025 | 5.35M sh |
| Operating Cash Flow | Q2 2025 · Jan 31, 2025 | −$23.57K |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | −$6.62K |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | −$67.24K |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | −$48.01K |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$23.39K |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | −$9.27K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$16.44K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.15K |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $148.57K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $125K |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $148.57K |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $125K |
| Current Assets | Q2 2025 · Jan 31, 2025 | $10.4K |
| Current Assets | Q2 2025 · Jul 31, 2024 | $39.2K |
| Total Assets | Q2 2025 · Jan 31, 2025 | $81.33K |
| Total Assets | Q2 2025 · Jul 31, 2024 | $101.61K |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $7.98K |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $41.57K |
| Sga Expense restated | Q2 2025 · Jan 31, 2024 | $4.83K |
| Sga Expense restated | Q2 2025 · Jan 31, 2024 | $12.72K |
| Net Income | Q2 2025 · Jan 31, 2025 | −$19.24K |
| Net Income | Q2 2025 · Jan 31, 2025 | −$43.85K |
| Net Income | Q2 2025 · Jan 31, 2024 | $7.17K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$10.42K |
| Operating Income | Q2 2025 · Jan 31, 2025 | −$19.24K |
| Operating Income | Q2 2025 · Jan 31, 2025 | −$43.85K |
| Operating Income | Q2 2025 · Jan 31, 2024 | $7.17K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$10.42K |
| Revenue | Q2 2025 · Jan 31, 2025 | $23K |
| Revenue | Q2 2025 · Jul 31, 2024 | $21.7K |
| Revenue | Q2 2025 · Jan 31, 2024 | $21.7K |
| Revenue | Q2 2025 · Jan 31, 2024 | $21.7K |